Arcus Biosciences RCUS
NYSE RCUS
$24.46 -0.76 (-3.01%)
At close: Oct 2, 2026 · 4:00 PM EDT

Arcus Biosciences (RCUS) Price to Earnings (2021 - 2022)

Updated

Arcus Biosciences' Price to Earnings came in at 23.80 for Q3 2022, down 13.3% from the prior quarter.

Analysis

Arcus Biosciences (RCUS) Price to Earnings (2021 - 2022) Analysis & Trends

For FY2021, Arcus Biosciences' Price to Earnings was 54.05.

  • Business Quant data shows RCUS's Price to Earnings at 27.44 (Q2 2022), 39.25 (Q1 2022) and 54.05 (Q4 2021) in the three quarters before Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Arcus Biosciences 3.11 Bn -229.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 23.80
Jun 30, 2022 27.44
Mar 31, 2022 39.25
Dec 31, 2021 54.05
API Access

Arcus Biosciences Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=RCUS&period=max&api_key=YOUR_API_KEY